ARTICLE | Company News
Cantabio, Purdue University deal
August 1, 2016 7:00 AM UTC
Cantabio and the university’s Purdue Research Foundation partnered to evaluate small molecule chaperone candidates from the biotech that target DJ-1 (PARK7) to treat neurodegenerative diseases, inclu...